Updates in Antimicrobial Selection for uUTIs
Hear Lillian Abbo, MD, MBA, FIDSA, an infectious disease specialist, discuss her insights on appropriate, evidence-based antimicrobial selection, antimicrobial stewardship, and optimizing outcomes in the management of uncomplicated UTIs.
Decera Clinical Education Infectious Disease Podcast · Lillian Abbo MD MBA FIDSA
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Lillian Abbo, MD, MBA, FIDSA, discusses appropriate antimicrobial selection for managing uncomplicated UTIs, including:
- Balancing discrepancies in available guidelines
- Individualizing antimicrobial selection based on patient characteristics and local resistance patterns
- Incorporating tools, like antibiograms, into daily practice
- Being a good steward of currently available antimicrobial agents
- Planning ahead for emerging therapies for uncomplicated UTIs
Presenter:
Lillian Abbo, MD, MBA, FIDSA
Associate Chief Medical Officer
Infectious Diseases
Jackson Health System
Professor of Clinical Infectious Diseases
University of Miami Miller School of Medicine
Miami Transplant Institute
Miami, Florida
Find other program activities here:
- “Uncomplicated” Doesn’t Mean Easy: Recognizing the Burden and Preventing Treatment Failure of Uncomplicated UTIs
- Slides on “Uncomplicated” Doesn’t Mean Easy: Recognizing the Burden and Preventing Treatment Failure of Uncomplicated UTIs
- Podcast 1: Burden on Uncomplicated Urinary Tract Infections
- Podcast 3: When Things Get Complicated: Managing uUTIs in Acute Care
- ClinicalThought: Not Always an Easy Task: Antimicrobial Stewardship for Uncomplicated UTIs
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.